All In Biotech

Free tool

FAERS Monitor: Achromycin V

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 050278 or its brand name (Achromycin V, Tetracycline Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

779

Serious

507

65% of reports

Hospitalization

290

Death reported

212

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • off label use226
  • drug hypersensitivity154
  • hypersensitivity125
  • pneumonia106
  • intentional product use issue104
  • pain in extremity96
  • vomiting95
  • mobility decreased94
  • arthralgia93
  • neck pain91
  • hepatitis88
  • nausea88
  • urticaria88
  • drug ineffective86
  • injury85

Reports by year received

View as table
YearReports
20043
20052
20062
20072
200811
20092
20109
201110
201215
20136
20145
201516
201634
201739
201826
201942
202074
202144
202255
202362
2024162
2025122
202636

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,380 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
hepatitisSignal8893.276.57,915
neck painSignal9144.036.33,788
mobility decreasedSignal9435.429.33,112
injurySignal8532.726.72,585
intentional product use issueSignal10432.126.83,111
drug hypersensitivitySignal15421.518.73,015
hypersensitivitySignal12518.215.52,030
urticariaSignal8814.211.71,074
pneumoniaSignal1068.87.4741
pain in extremitySignal968.87.3665
off label useSignal2267.06.21,199
arthralgiaSignal936.05.0394
vomitingSignal955.54.5349
nauseaSignal883.02.5120
drug ineffective861.81.429

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.